{"id":194417,"name":"ASSOCIATION FOR ACCESSIBLE MEDICINES","slug":"association-for-accessible-medicines","state":"DC","country":"United States of America","description":"National trade organization representing the interests of generic drug manufacturers.","totalSpending":980000,"filings":32,"yearlySpending":[{"year":2018,"income":120000},{"year":2019,"income":120000},{"year":2020,"income":120000},{"year":2021,"income":120000},{"year":2022,"income":120000},{"year":2023,"income":120000},{"year":2024,"income":120000},{"year":2025,"income":140000}],"issues":[{"code":"CPT","display":"Copyright/Patent/Trademark"},{"code":"HCR","display":"Health Issues"},{"code":"LBR","display":"Labor Issues/Antitrust/Workplace"},{"code":"TRD","display":"Trade (domestic/foreign)"}],"firms":["THE GIBSON GROUP, LLC"],"lobbyists":["JOSEPH GIBSON"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","White House Office","Federal Trade Commission (FTC)"],"sampleDescriptions":["Sovereign immunity issues relating to patent ownership.\nPatent settlement issues.","Drug competition issues.\nH.R.2212: CREATES Act of 2017.","Drug competition issues.\nH.R.2212: CREATES Act of 2017.","Drug competition issues.\nH.R.2212: CREATES Act.","Sovereign immunity issues relating to patent ownership.\nPatent settlement issues.\nIssues relating to the treatment of pharmaceutical patents in inter pares reviews."]}